Fundamental Analysis
61 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +141.3% | +341.1% | 3 / 3 | -2.4% | +0.58 pp | +1.30 pp | +11.2% | 1.25 | 19.64 | 413 | −2,4% | 9,0 | +141,3% | 19.64 | 21.86 | −10,1% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 31.300 (close price on 2026-09-25)EPS (TTM): 1.593
Financial charts
1.Revenue & growth
VND bn413Q2/26
1.Revenue & growth
VND bn413Q2/26
2.Profit & growth
VND bn9,03Q2/26
3.Profit mix (Penman)
VND bn32,8Q2/26
4.Margins & cost structure
%5.0%Q2/26
5.Returns & cash cycle
% · days11.1%Q2/26
6.Earnings quality & cash
VND bn-60,6Q2/26
7.Asset structure
VND bn720Q2/26
8.Funding & debt health
VND bn · times720Q2/26
9.Revenue backlog
VND bn4,24Q2/26
10.Valuation
times · %19,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %541Q2/26
Adjusted EPS growth, latest quarter
141%
Average adjusted EPS growth, 3 quarters
341%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26